• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃腺癌中miRNA表达谱分析

Analysis of expression profile of miRNA in stomach adenocarcinoma.

作者信息

Huo Qianzhu

机构信息

Department of Physical Examination, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.

出版信息

J BUON. 2017 Sep-Oct;22(5):1154-1159.

PMID:29135097
Abstract

PURPOSE

Stomach adenocarcinoma (STAD) has become the second main cause of cancer death around the world, and accumulated evidence has suggested that micro-RNAs (miRNAs) are likely to be served as indicator for diagnosis and prognosis in a variety of tumors. The purpose of this study was to discover the miRNAs acting as independent prognostic factors of STAD and to provide reference for the STAD diagnosis and prognosis.

METHODS

In this study, we analyzed the clinical data collected from 393 STAD cases of the Cancer Genome Atlas (TCGA;USA) and the expression data of 1881 miRNAs to screen miRNAs that were associated with STAD via Cox regression univariate analysis and those miRNAs with independent effect on the prognosis of STAD via Cox regression multivariate analysis.

RESULTS

We found differential expressions of 218 miRNAs in STAD tumors and normal tissues, and a key role of miR- 7 in STAD. In Cox regression multivariate analysis, miR- 378i (p=0.0010), miR-7-3 (p=0.01), miR-137 (p=0.03) and miR-372 (p=0.04) were independent prognostic factors, for which we performed Kaplan-Meier analysis, and the results showed that there was a statistically significant difference in comparison of the survival duration between the highexpression and low-expression of miR-7-3 groups, but no differences were identified between the groups of miR-378i (p=0.7), miR-137 (p=0.11) and miR-372 (p=0.13).

CONCLUSION

miR-7-3 is proved to be an independent prognostic indicator for STAD and this study confirmed that tumor-specific miRNA can predict the progression and prognosis of STAD.

摘要

目的

胃腺癌(STAD)已成为全球癌症死亡的第二大主要原因,越来越多的证据表明,微小RNA(miRNA)可能作为多种肿瘤诊断和预后的指标。本研究旨在发现可作为STAD独立预后因素的miRNA,为STAD的诊断和预后提供参考。

方法

在本研究中,我们分析了从美国癌症基因组图谱(TCGA)收集的393例STAD病例的临床数据以及1881种miRNA的表达数据,通过Cox回归单因素分析筛选与STAD相关的miRNA,并通过Cox回归多因素分析筛选对STAD预后有独立影响的miRNA。

结果

我们发现218种miRNA在STAD肿瘤组织和正常组织中存在差异表达,且miR-7在STAD中起关键作用。在Cox回归多因素分析中,miR-378i(p = 0.0010)、miR-7-3(p = 0.01)、miR-137(p = 0.03)和miR-372(p = 0.04)是独立的预后因素,我们对其进行了Kaplan-Meier分析,结果显示,miR-7-3高表达组和低表达组的生存时间比较有统计学意义,但miR-378i组(p = 0.7)、miR-137组(p = 0.11)和miR-372组(p = 0.13)之间未发现差异。

结论

miR-7-3被证明是STAD的独立预后指标,本研究证实肿瘤特异性miRNA可预测STAD的进展和预后。

相似文献

1
Analysis of expression profile of miRNA in stomach adenocarcinoma.胃腺癌中miRNA表达谱分析
J BUON. 2017 Sep-Oct;22(5):1154-1159.
2
A novel microRNA signature predicts survival in stomach adenocarcinoma.一种新型微小RNA特征可预测胃腺癌的生存率。
Oncotarget. 2017 Apr 25;8(17):28144-28153. doi: 10.18632/oncotarget.15961.
3
Identification of miRNA biomarkers for stomach adenocarcinoma.胃腺癌的 miRNA 生物标志物鉴定。
BMC Bioinformatics. 2022 May 16;23(1):181. doi: 10.1186/s12859-022-04719-6.
4
Use of a Four-miRNA Panel as a Biomarker for the Diagnosis of Stomach Adenocarcinoma.四联微小 RNA 标志物 panel 用于胃腺癌的诊断。
Dis Markers. 2020 Nov 7;2020:8880937. doi: 10.1155/2020/8880937. eCollection 2020.
5
Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.全基因组分析以鉴定一种预测胃腺癌患者生存情况的新型微小RNA特征。
J Cancer. 2019 Oct 17;10(25):6298-6313. doi: 10.7150/jca.33250. eCollection 2019.
6
STAT4-mediated down-regulation of miR-3619-5p facilitates stomach adenocarcinoma by modulating TBC1D10B.STAT4 介导的 miR-3619-5p 下调通过调节 TBC1D10B 促进胃腺癌。
Cancer Biol Ther. 2020 Jul 2;21(7):656-664. doi: 10.1080/15384047.2020.1754690. Epub 2020 May 13.
7
Identification of the key miRNAs associated with survival time in stomach adenocarcinoma.胃腺癌中与生存时间相关的关键微小RNA的鉴定。
Oncol Lett. 2017 Oct;14(4):4563-4572. doi: 10.3892/ol.2017.6792. Epub 2017 Aug 23.
8
Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.胃腺癌患者长链非编码 RNA 预后风险模型的鉴定与构建。
Dis Markers. 2021 Feb 24;2021:8895723. doi: 10.1155/2021/8895723. eCollection 2021.
9
A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma.基于 MicroRNA 的五基因signature 预测胃腺癌的预后和免疫治疗。
Curr Med Chem. 2024;31(17):2378-2399. doi: 10.2174/0109298673281631231127051017.
10
Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.微小RNA的鉴定与功能表征揭示了其在胃癌进展中的潜在作用。
Clin Transl Oncol. 2017 Feb;19(2):162-172. doi: 10.1007/s12094-016-1516-y. Epub 2016 May 12.

引用本文的文献

1
Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.全基因组分析以鉴定一种预测胃腺癌患者生存情况的新型微小RNA特征。
J Cancer. 2019 Oct 17;10(25):6298-6313. doi: 10.7150/jca.33250. eCollection 2019.
2
Study on miRNAs in Pan-Cancer of the Digestive Tract Based on the Illumina HiSeq System Data Sequencing.基于 Illumina HiSeq 系统数据测序的消化道多癌种 miRNAs 研究。
Biomed Res Int. 2019 Oct 15;2019:8016120. doi: 10.1155/2019/8016120. eCollection 2019.
3
A six-microRNA signature to predict outcomes of patients with gastric cancer.
一个六 miRNA -signature 预测胃癌患者的预后。
FEBS Open Bio. 2019 Jan 31;9(3):538-547. doi: 10.1002/2211-5463.12593. eCollection 2019 Mar.
4
Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.基于全基因组鉴定的新型 miRNA 标志物预测胃癌患者的复发。
Mol Oncol. 2018 Dec;12(12):2072-2084. doi: 10.1002/1878-0261.12385. Epub 2018 Oct 10.